Antimicrobial Therapy for Infections Due to Pseudomonas Aeruginosa With Difficult-to-treat Resistance: a Real-world, Prospective, Multicenter Cohort Study
Status: Recruiting
Location: See all (47) locations...
Study Type: Observational
SUMMARY
The primary objective of the ADDICT study is to assess and compare the clinical efficacy of available options for antimicrobial therapy (new beta-lactam/beta-lactamase inhibitor combination, cefiderocol or older agents such as aminoglycosides and colistin) in unselected patients with infection due to difficult-to-treat P. aeruginosa.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• All patients aged 18 or over and requiring intravenous definite antimicrobial therapy for a DTR P. aeruginosa infection
Locations
Other Locations
France
CHU Amiens
NOT_YET_RECRUITING
Amiens
CH Argenteuil
NOT_YET_RECRUITING
Argenteuil
CH Bayonne
NOT_YET_RECRUITING
Bayonne
CHU de BESANCON
NOT_YET_RECRUITING
Besançon
CH Bethune
NOT_YET_RECRUITING
Béthune
CHU Avicenne
NOT_YET_RECRUITING
Bobigny
CH Bourgoin-Jallieu
NOT_YET_RECRUITING
Bourgoin
CH Métropole Savoie
NOT_YET_RECRUITING
Chambéry
Ch de Chartres
NOT_YET_RECRUITING
Chartres
CHU Clermont Ferrand
NOT_YET_RECRUITING
Clermont-ferrand
CHI Créteil
NOT_YET_RECRUITING
Créteil
CHU Henri Mondor
NOT_YET_RECRUITING
Créteil
CHI Elbeuf Louviers
NOT_YET_RECRUITING
Elbeuf
CH Sud Essone
NOT_YET_RECRUITING
Étampes
Hopital Raymond Poincaré
NOT_YET_RECRUITING
Garches
CHU Grenoble
NOT_YET_RECRUITING
Grenoble
CH Haguenau
NOT_YET_RECRUITING
Haguenau
CHD Vendée
RECRUITING
La Roche-sur-yon
Hopital Bicetre
NOT_YET_RECRUITING
Le Kremlin-bicêtre
CHU Limoges
NOT_YET_RECRUITING
Limoges
CHU Lyon
NOT_YET_RECRUITING
Lyon
CHU Lyon Sud
NOT_YET_RECRUITING
Lyon
CHY Lyon
NOT_YET_RECRUITING
Lyon
Hopital Saint-Joseph Saint Luc
NOT_YET_RECRUITING
Lyon
CHU Montpellier
NOT_YET_RECRUITING
Montpellier
CHRU Nancy
RECRUITING
Nancy
Chu de Nantes
NOT_YET_RECRUITING
Nantes
CHU de Nice
NOT_YET_RECRUITING
Nice
Centre Hospitalier Universitaire d'Orléans
RECRUITING
Orléans
Hopital Bichat
RECRUITING
Paris
Hopital Cochin
NOT_YET_RECRUITING
Paris
Hôpital Européen Georges Pompidou
NOT_YET_RECRUITING
Paris
Hopital LARIBOISIERE
NOT_YET_RECRUITING
Paris
Hopital Pitie Salpetriere
NOT_YET_RECRUITING
Paris
Hopital Saint-Antoine
NOT_YET_RECRUITING
Paris
Hôpital Saint-Louis
NOT_YET_RECRUITING
Paris
CH PAU
NOT_YET_RECRUITING
Pau
Centre Hospitalier de Périgueux
NOT_YET_RECRUITING
Périgueux
CH Perpignan
NOT_YET_RECRUITING
Perpignan
CHU Reims
NOT_YET_RECRUITING
Reims
CH Saint-Lô
NOT_YET_RECRUITING
Saint-lô
CHRU Strasbourg Haute Pierre
NOT_YET_RECRUITING
Strasbourg
CHU Strasbourg
NOT_YET_RECRUITING
Strasbourg
Hopital Foch
NOT_YET_RECRUITING
Suresnes
CH Tourcoing
NOT_YET_RECRUITING
Tourcoing
CH Vannes
NOT_YET_RECRUITING
Vannes
Hôpital Nord-Ouest de Villefranche sur Saone
NOT_YET_RECRUITING
Villefranche-sur-saône
Contact Information
Primary
FRANCOIS BARBIER, Professor
francois.barbier@chu-orleans.fr
+33238229939
Time Frame
Start Date: 2025-03-11
Estimated Completion Date: 2027-01
Participants
Target number of participants: 600
Treatments
1
patients with invasive P. aeruginosa DTR infection requiring definitive intravenous antibiotic therapy
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Régional d'Orléans